Who owns ARRIVENT BIOPHARMA INC COM?
- Ticker: AVBP
- CUSIP Number: 04272n102
Tip: Access positions for across all investors
Analyze quarterly positions in Arrivent Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Arrivent Biopharma stock
Who bought or sold ARRIVENT BIOPHARMA INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hillhouse Capital Advisors | 4.5M | $105M | 0% | Sep 2024 |
|
| OrbiMed Advisors | 3.0M | $71M | 0% | Sep 2024 |
|
| Octagon Capital Advisors | 2.0M | $46M | 10% | Sep 2024 |
|
| BlackRock | 1.9M | $45M | 100% | Sep 2024 |
|
| Suvretta Capital Management | 1.7M | $32M | 10% | Jun 2024 |
|
| Sofinnova Ventures | 1.7M | $40M | 0% | Sep 2024 |
|
| Novo A/S | 1.5M | $35M | 0% | Sep 2024 |
|
| General Catalyst Group Management | 1.5M | $35M | 0% | Sep 2024 |
|
| Sc China Holding | 663k | $19M | 0% | Sep 2024 |
|
| BlackRock | 663k | $12M | 1% | Jun 2024 |
|
| Vanguard Group | 651k | $12M | 0% | Jun 2024 |
|
| Geode Capital Management | 597k | $14M | 154% | Sep 2024 |
|
| Cormorant Asset Management | 515k | $9.6M | 0% | Jun 2024 |
|
| Perceptive Advisors | 415k | $9.8M | 0% | Sep 2024 |
|
| Northern Trust | 231k | $5.4M | 194% | Sep 2024 |
|
| Charles Schwab Investment Management | 202k | $4.8M | 154% | Sep 2024 |
|
| State Street Corporation | 154k | $2.8M | 26% | Jun 2024 |
|
| Woodline Partners | 121k | $2.8M | 21% | Sep 2024 |
|
| Marshall Wace | 85k | $2.0M | 100% | Sep 2024 |
|
| Bank of New York Mellon | 68k | $1.6M | 129% | Sep 2024 |
|
| Ghisallo Capital Management | 50k | $928k | 0% | Jun 2024 |
|
| Bank of America Corporation | 43k | $1.0M | 587% | Sep 2024 |
|
| Barclays | 42k | $976k | 1125% | Sep 2024 |
|
| Morgan Stanley | 41k | $768k | 96% | Jun 2024 |
|
| Hidden Lake Asset Management | 37k | $689k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 34k | $790k | 165% | Sep 2024 |
|
| ALPS Advisors | 27k | $645k | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 22k | $516k | 33% | Sep 2024 |
|
| Citigroup | 20k | $479k | 843% | Sep 2024 |
|
| Nuveen Asset Management | 18k | $326k | 36% | Jun 2024 |
|
| MetLife Investment Advisors | 16k | $384k | 169% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 16k | $363k | 223% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 15k | $360k | 100% | Sep 2024 |
|
| AlphaCentric Advisors | 15k | $353k | -83% | Sep 2024 |
|
| Jpmorgan Chase & Co | 12k | $293k | 183% | Sep 2024 |
|
| SG Americas Securities | 12k | $280k | 100% | Sep 2024 |
|
| Jane Street | 11k | $250k | -31% | Sep 2024 |
|
| Wells Fargo & Company | 10k | $243k | 187% | Sep 2024 |
|
| Rafferty Asset Management | 9.5k | $224k | 100% | Sep 2024 |
|
| T. Rowe Price Associates | 9.3k | $220k | 100% | Sep 2024 |
|
| D. E. Shaw & Co | 8.8k | $206k | 100% | Sep 2024 |
|
| AQR Capital Management | 8.7k | $204k | 100% | Sep 2024 |
|
| New York State Common Retirement Fund | 5.8k | $136k | 101% | Sep 2024 |
|
| Royal Bank of Canada | 3.5k | $79k | 274% | Sep 2024 |
|
| Summit Investment Advisors | 2.9k | $67k | 191% | Sep 2024 |
|
| California State Teachers Retirement System | 2.1k | $49k | 190% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.7k | $40k | 0% | Sep 2024 |
|
| Tower Research Capital | 1.5k | $28k | 147% | Jun 2024 |
|
| Amalgamated Bank | 963.00 | $23k | 78% | Sep 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 888.00 | $21k | 128% | Sep 2024 |
|
| SRS Capital Advisors | 119.00 | $2.8k | 0% | Sep 2024 |
|
| CWM | 94.00 | $2.0k | 62% | Sep 2024 |
|
| Capital Performance Advisors | 67.00 | $1.6k | 100% | Sep 2024 |
|
| Sterling Capital Management | 59.00 | $1.4k | 100% | Sep 2024 |
|
| Ronald Blue Trust | 39.00 | $723.001500 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 27.00 | $634.999500 | 0% | Sep 2024 |
|
| GAMMA Investing | 25.00 | $588.000000 | 150% | Sep 2024 |
|
| Rothschild Investment | 10.00 | $235.000000 | 100% | Sep 2024 |
|
Who sold out of Arrivent Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Farallon Capital Management | Mar 2024 | 152k | $2.7M |
| Millennium Management | Jun 2024 | 12k | $225k |